Estabrook Capital Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Estabrook Capital Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,500	Closed	-$7.13K	–	406
2017 Q1	$7.13K	Hold	1,500	–	–	﹤0.01%	355
2016 Q4	$8.4K	Hold	1,500	–	–	﹤0.01%	358
2016 Q3	$8.32K	Hold	1,500	–	–	﹤0.01%	354
2016 Q2	$10.5K	Hold	1,500	–	–	﹤0.01%	353
2016 Q1	$9.91K	Hold	1,500	–	–	﹤0.01%	353
2015 Q4	$15.4K	Hold	1,500	–	–	﹤0.01%	331
2015 Q3	$17.7K	Hold	1,500	–	–	﹤0.01%	322
2015 Q2	$13.7K	Hold	1,500	–	–	﹤0.01%	333
2015 Q1	$9.31K	Hold	1,500	–	–	﹤0.01%	381
2014 Q4	$8.4K	Hold	1,500	–	–	﹤0.01%	394
2014 Q3	$8.84K	Hold	1,500	–	–	﹤0.01%	394
2014 Q2	$10.3K	Hold	1,500	–	–	﹤0.01%	382
2014 Q1	$10.8K	Hold	1,500	–	–	﹤0.01%	384
2013 Q4	$9.91K	Hold	1,500	–	–	﹤0.01%	381
2013 Q3	$10.9K	Buy	+1,500	New	+$10.1K	﹤0.01%	383

Other funds holding JNP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Estabrook Capital Management's JNP Position: Q2 2017 in Review

Estabrook Capital Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2017, closing a stake of 1,500 shares — an estimated $7.13K sold.

Estabrook Capital Management first reported a position in JNP in Q3 2013 and held it in 15 quarters. The position peaked at $17.7K in Q3 2015. 33 funds tracked by Wall St. Rank hold JNP as of Q2 2017.

Estabrook Capital Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Estabrook Capital Management sold 1,500 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2017, an estimated $7.13K.
Estabrook Capital Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 15 quarters.
Estabrook Capital Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $17.7K in Q3 2015.
33 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2017.

Based on Estabrook Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.